I remember when I was first diagnosed with a prostate cancer recurrence, when I was told that I had advanced prostate cancer. More than any other times that I have been told I have cancer (I have melanoma, thyroid cancer, renal cancer and advanced prostate cancer) I felt the world stopped and my life was [...]
Cabozantinib (XL184) is an orally bioavailable tyrosine kinase inhibitor with activity against MET and vascular endothelial growth factor receptor 2. It is designed to target the men with castration resistant prostate cancer (CRPC). Results from a phase II randomized discontinuation trial with an expansion cohort of XL184 have recently been released. The trial included men [...]
We are constantly hearing about possible ways to control prostate cancer through diet. Often, researchers point out that in Asian cultures, even in the cultures that have a similar rate of prostate cancer, the disease seems to progress in Western cultures, but not in the Asian cultures. A University of Colorado Cancer Center study published [...]
I have said many times that one of the more important issues facing our use of Provenge is when to start it and how to sequence this treatment with the other newly approved agents that have recently become available for men with advanced prostate cancer. There is occasional conversation that Provenge is already antiquated due [...]
Everyone knows that exercise is good for both people with and without cancer, including advanced prostate cancer. For us advanced prostate cancer survivors, going on and off therapy probably makes exercise evn more important than for the general population. It is well known that people with stronger, leaner bodies have more energy, are healthier and [...]